Neurol. praxi. 2025;26(3):240-243 | DOI: 10.36290/neu.2024.061

Anxiety disorders in epilepsy

MUDr. Dominika Jarčušková, PhD.1, MUDr. Aneta Bednářová, PhD.2
1 1. psychiatrická klinika, Lekárska fakulta UPJŠ v Košiciach, Univerzitná nemocnica L. Pasteura, Košice
2 2. psychiatrická klinika, Lekárska fakulta UPJŠ v Košiciach, Univerzitná nemocnica L. Pasteura, Košice

Psychiatric comorbidities of epilepsy, including anxiety disorders, have a high prevalence and massive impact on the daily lives of patients. These disorders manifest through emotional and physical changes and can influence patients' cognitive skills. They have a bidirectional relationship with epilepsy, caused by similar neurobiological correlates of both disorders. Their treatment is based on combining changes in patients' daily life, pharmacotherapy, and psychotherapy. This paper aims to review anxiety disorders in patients with epilepsy, discussing their prevalence, neurobiological correlates, their influence on the quality of life in patients, their diagnosis, and treatment strategies.

Keywords: anxiety, epilepsy, quality of life, anti-depressive medication, neurobiology of anxiety.

Received: September 1, 2024; Revised: September 1, 2024; Accepted: September 11, 2024; Prepublished online: September 11, 2024; Published: July 4, 2025  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Jarčušková D, Bednářová A. Anxiety disorders in epilepsy. Neurol. praxi. 2025;26(3):240-243. doi: 10.36290/neu.2024.061.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • PDF will be unlocked 4.7.2026

    References

    1. . Asadi-Pooya AA, Schilling CA, Glosser D, et al. Health locus of control in patients with epilepsy and its relationship to anxiety, depression, and seizure control. Epilepsy Behav. 2007;11:347-350. doi:10.1016/j.yebeh.2007.06.008. Go to original source... Go to PubMed...
    2. . Bandelow B, Boerner JR, Kasper S, et al. The diagnosis and treatment of generalized anxiety disorder. Dtsch Arztebl Int. 2013;110:300-309. Go to original source... Go to PubMed...
    3. . Beyenburg S, Mitchell AJ, Schmidt D, et al. Anxiety in patients with epilepsy: systematic review and suggestions for clinical management. Epilepsy Behav. 2005;7:161-171. doi:10.1016/j.yebeh.2005.05.014. Go to original source... Go to PubMed...
    4. . Brandt C, Mula M. Anxiety disorders in people with epilepsy. Epilepsy Behav. 2016;59:87-91. doi:10.1016/j.yebeh.2016.03.020. Go to original source... Go to PubMed...
    5. . Brandt C, Schoendienst M, Trentowska M, et al. Efficacy and safety of pregabalin in refractory focal epilepsy with and without comorbid anxiety disorders - results of an open-label, parallel group, investigator-initiated, proof-of-concept study. Epilepsy Behav. 2013;29:298-304. doi:10.1016/j.yebeh.2013.08.004. Go to original source... Go to PubMed...
    6. . Campbell C, Cavalleri GL, Delanty N. Exploring the genetic overlap between psychiatric illness and epilepsy: a review. Epilepsy & Behavior. 2020;102:106669. Go to original source... Go to PubMed...
    7. . Fiest KM, Patten SB, Jetté N. Screening for depression and anxiety in epilepsy. Neurol Clin. 2016;34(2):351-361. doi:10.1016/j.ncl.2015.11.003. Go to original source... Go to PubMed...
    8. . Gomez-Arias B, Crail-Melendez D, Lopez-Zapata R, et al. Severity of anxiety and depression are related to a higher perception of adverse effects of antiepileptic drugs. Seizure. 2012;21:588-594. doi:10.1016/j.seizure.2012.06.003. Go to original source... Go to PubMed...
    9. . Guo Y, Ding XY, Lu RY, et al. Depression and anxiety are associated with reduced antiepileptic drug adherence in Chinese patients. Epilepsy Behav. 2015;50:91-95. doi:10.1016/j.yebeh.2015.06.042. Go to original source... Go to PubMed...
    10. . Hagemann A, May TW, Nieder E, et al. Quality of life, anxiety and depression in adult patients after add-on of levetiracetam and conversion to levetiracetam monotherapy. Epilepsy Res. 2013;104:140-150. doi:10.1016/j.eplepsyres.2012.08.005. Go to original source... Go to PubMed...
    11. . Hesdorffer DC, Hauser WA, Olafsson E, et al. Depression and suicide attempt as risk factors for incident unprovoked seizures. Ann Neurol. 2006;59:35-41. doi:10.1016/j.eplepsyres.2007.05.001. Go to original source... Go to PubMed...
    12. . Jacoby A, Snape D, Lane S, et al. Self-reported anxiety and sleep problems in people with epilepsy and their association with quality of life. Epilepsy Behav. 2015;43:149-158. doi:10.1016/j.yebeh.2014.09.071. Go to original source... Go to PubMed...
    13. . Jarčušková D, Palušná M, Gazda J, et al. Which clinical and neuropsychological factors are responsible for cognitive impairment in patients with epilepsy? Int J Public Health. 2020;65(6):947-956. doi:10.1007/s00038-020-01401-7. Go to original source... Go to PubMed...
    14. . Kanner AM. Psychiatric issues in epilepsy: the complex relation of mood, anxiety disorders, and epilepsy. Epilepsy Behav. 2009;15:83-87. doi:10.1016/j.yebeh.2009.02.034. Go to original source... Go to PubMed...
    15. . Mensah SA, Beavis JM, Thapar AK, et al. A community study of the presence of anxiety disorder in people with epilepsy. Epilepsy Behav. 2007;11(1):118-124. doi:10.1016/j.yebeh.2007.04.012. Go to original source... Go to PubMed...
    16. . Meyer B, Weiss M, Holtkamp M, et al. Effects of an epilepsy-specific Internet intervention (Emyna) on depression: results of the ENCODE randomized controlled trial. Epilepsia. 2019;60(4):656-668. doi:10.1111/epi.14673. Go to original source... Go to PubMed...
    17. . Mula M. Treatment of anxiety disorders in epilepsy: an evidence-based approach. Epilepsia. 2013;54(1):13-18. doi:10.1111/epi.12101. Go to original source... Go to PubMed...
    18. . Mula M, Pini S, Cassano GB. The role of anticonvulsant drugs in anxiety disorders: a critical review of the evidence. J Clin Psychopharmacol. 2007;27:263-272. doi:10.1097/jcp.0b013e318059361a. Go to original source... Go to PubMed...
    19. . Niu C, Li P, Du X, et al. Risk factors for anxiety in patients with epilepsy: A meta-analysis. Epilepsy Behav. 2024;153:109665. doi:10.1016/j.yebeh.2024.109665. Go to original source... Go to PubMed...
    20. . Parkerson HA, Thibodeau MA, Brandt CP, et al. Cultural-based biases of the GAD-7. J Anxiety Disord. 2015;31:38-42. doi:10.1016/j.janxdis.2015.01.005. Go to original source... Go to PubMed...
    21. . Penninx BW, Pine DS, Holmes EA, et al. Anxiety disorders. Lancet. 2021;397(10277):914-927. doi:10.1016/S0140-6736(21)00359-7. Go to original source... Go to PubMed...
    22. . Rogawski MA, Löscher W. The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions. Nat Med. 2004;10:685-692. doi:10.1038/nm1074. Go to original source... Go to PubMed...
    23. . Salpekar JA, Ma GJ, Mietchen J, Mani J, Jones JE. Treat­ment of Comorbid Anxiety and Epilepsy. J Neuropsychiatry Clin Neurosci. 2023;35(3):218-227. doi: 10.1176/appi.neuropsych.20220116. Epub 2023 Feb 14. PMID: 36785943. Go to original source... Go to PubMed...
    24. . Seo JG, Cho YW, Lee SJ, et al. Validation of the Generalized Anxiety Disorder-7 in people with epilepsy: a MEPSY study. Epilepsy Behav. 2014;35:59-63. doi:10.1016/j.yebeh.2014.04.005. Go to original source... Go to PubMed...
    25. . Sirven JI, Schachter SC.Seizure Medications and Mood. Epilepsy Foundation. 2022. [Internet 1. 9. 2024]. Available from: https://www.epilepsy.com/complications-risks/moods-behavior/medications.
    26. . Stahl SM. Brainstorms: symptoms and circuits, part 2: anxiety disorders. J Clin Psychiatry. 2003;64:1408-1409. doi:10.4088/jcp.v64n1201. Go to original source... Go to PubMed...
    27. . Stern AF. The Hospital Anxiety and Depression Scale. Occup Med. 2014;67(6):361. doi:10.1093/occmed/kqu024. Go to original source... Go to PubMed...
    28. . Šlepecký M, Praško J, Grendelová M, Jandová K. Komplexný manažment adolescentného a dospelého pacienta s generalizovanou úzkostnou poruchou. [Internet 1. 9. 2024]. Available from: https://health.gov.sk/Zdroje?/Sources/dokumenty/SDTP/standardy/1-6-2020/098_KP_Komplexny_manazment_adolescentneho_a_dospeleho_pacienta_s_generalizovanou_uzkostnou_poruchou.pdf.
    29. . Teixeira AL. Peri-Ictal and Para-Ictal Psychiatric Phenomena: A Relatively Common Yet Unrecognized Disorder. Curr Top Behav Neurosci. 2022;55:171-181. doi: 10.1007/7854_2021_223. PMID: 33728598. Go to original source... Go to PubMed...
    30. . Vinti V, Dell'Isola GB, Tascini G, et al. Temporal Lobe Epilepsy and Psychiatric Comorbidity. Front Neurol. 2021;12:775781. doi: 10.3389/fneur.2021.775781. Go to original source... Go to PubMed...

    Return to the content


    Neurology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.